biotech

biotech Articles

Idera Pharmaceuticals is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end up being...
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Should Trump’s new health care bill pass, investors might gain confidence that the president can actually push his agenda, while a failure to pass could send the markets lower.
Regenxbio plans to offer more than 3 million shares of common stock in a secondary offering valued up to more than $87 million.
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.
These are four top stocks to buy in a sector that has much more value than many on Wall Street. All are rated Buy at Jefferies and have outstanding upside potential.
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on the day,...
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Markets may be slowing down and taking a step back after hitting new highs in what has been known as the Trump rally. Still, a few stocks in the health care sector were are absolutely screaming...
In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a large cap leader.
Here are three biotech companies that not only have data that could prove to be huge, but their shares have been absolutely hammered over the last year, offering aggressive accounts the best entry...
Opko Health and a few other biopharma companies made massive runs on Thursday.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.